Twenty-six articles were excluded due to the lack of SMARCA4-mutation NSCLC survival outcomes, primary prognostic modeling, lack of incorrect patient population (i.e., sarcomatoid histology), review articles, and being written in non-English. This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.